About Theratechnologies
Theratechnologies is a company based in Montreal (Canada) founded in 1993 was acquired by CB Biotechnology in July 2025.. The company has 105 employees as of November 30, 2024. Theratechnologies has completed 1 acquisition, including Katana Biopharma. Theratechnologies operates in a competitive market with competitors including NGM Biopharmaceuticals, MannKind Corp, Rhythm Pharmaceuticals, Corcept and ViaCyte, among others.
- Headquarter Montreal, Canada
- Employees 105 as on 30 Nov, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Theratechnologies Inc.
-
Annual Revenue
$81.36 M (USD)5.97as on Nov 30, 2024
-
Net Profit
$-7.87 M (USD)65.02as on Nov 30, 2024
-
EBITDA
$10.46 M (USD)289.07as on Nov 30, 2024
-
Latest Funding Round
- Investors
-
Employee Count
105
as on Nov 30, 2024
- Investments & Acquisitions
-
Acquired by
CB Biotechnology
(Jul 02, 2025)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Theratechnologies
Theratechnologies is a publicly listed company on the TSX with ticker symbol TH in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Leadership Team
13 people
Software Development Team
4 people
Senior Team
4 people
Finance and Accounting
3 people
Product Management Team
3 people
Human Resources and Administration
3 people
Sales and Marketing
3 people
Legal and Compliance
2 people
Unlock access to complete
Funding Insights of Theratechnologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Theratechnologies
Theratechnologies has secured backing from 1 investor. Prominent investors backing the company include CB Biotechnology. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Theratechnologies
Theratechnologies has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Katana Biopharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Targeted oncology technology platform is developed for cancer treatment.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Theratechnologies
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Theratechnologies Comparisons
Competitors of Theratechnologies
Theratechnologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NGM Biopharmaceuticals, MannKind Corp, Rhythm Pharmaceuticals, Corcept and ViaCyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biologics are developed for cardio-metabolic and liver diseases.
|
|
| domain | founded_year | HQ Location |
Developer of small-molecule drugs
|
|
| domain | founded_year | HQ Location |
Developer of peptide therapeutics for the treatment of rare genetic deficiencies
|
|
| domain | founded_year | HQ Location |
Developer of cortisol modulators for the treatment of various diseases
|
|
| domain | founded_year | HQ Location |
Cell therapy for diabetes is developed from stem cells.
|
|
| domain | founded_year | HQ Location |
Developer of therapies for treating nonalcoholic steatohepatitis and other liver and metabolic disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Theratechnologies
Frequently Asked Questions about Theratechnologies
When was Theratechnologies founded?
Theratechnologies was founded in 1993.
Where is Theratechnologies located?
Theratechnologies is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
How many employees does Theratechnologies have?
As of Nov 30, 2024, the latest employee count at Theratechnologies is 105.
What is the annual revenue of Theratechnologies?
Annual revenue of Theratechnologies is $81.36M as on Nov 30, 2024.
What does Theratechnologies do?
Theratechnologies was founded in 1993 in Montreal, Canada, within the biotechnology sector. Expertise in metabolism and GRF peptides is applied to tackle serious health conditions, with operations centered on product development and commercialization. The initial product, EGRIFT (tesamorelin for injection), received US FDA approval for treating excess abdominal fat linked to lipodystrophy in patients on certain HIV medications.
Who are the top competitors of Theratechnologies?
Theratechnologies's top competitors include Rhythm Pharmaceuticals, MannKind Corp and Corcept.
Is Theratechnologies publicly traded?
Yes, Theratechnologies is publicly traded on TSX under the ticker symbol TH.
How many acquisitions has Theratechnologies made?
Theratechnologies has made 1 acquisition, including Katana Biopharma.
Who are Theratechnologies's investors?
Theratechnologies has 1 investor. Key investors include CB Biotechnology.
What is Theratechnologies's ticker symbol?
The ticker symbol of Theratechnologies is TH on TSX.